ANIX Stock Summary and Trading Ideas (Anixa Biosciences | NASDAQ:ANIX)

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Anixa Biosciences trades on the NASDAQ stock market under the symbol ANIX.

As of March 3, 2025, ANIX stock price declined to $2.84 with 154,059 million shares trading.

ANIX has a beta of 0.29, meaning it tends to be less sensitive to market movements. ANIX has a correlation of 0.01 to the broad based SPY ETF.

ANIX has a market cap of $91.39 million. This is considered a Micro Cap stock.

In the last 3 years, ANIX traded as high as $6.45 and as low as $2.07.

The top ETF exchange traded funds that ANIX belongs to (by Net Assets): VTI, VXF, IWC, DFAC.

ANIX has underperformed the market in the last year with a price return of -19.1% while the SPY ETF gained +16.7%. ANIX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -14.2% and -9.6%, respectively, while the SPY returned -2.2% and -4.3%, respectively.

ANIX support price is $2.99 and resistance is $3.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANIX shares will trade within this expected range on the day.